StockData
Theriva Biologics, Inc. logo

Theriva Biologics, Inc. (TOVX) stock

TOVXNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$0.14+0.00 (+2.86%)

Close on Nov 18, 2026Market cap $6.61MP/E –Yield –

Theriva Biologics revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

For fiscal 2011 it was $0, down 100.0% from the year before.

Annual revenue

PeriodPeriod endValueChange
FY2011Dec 31, 2011$0-100.0%
FY2010Dec 31, 2010$2.61M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$0–
Q1 FY2026Mar 31, 2026$300.00K–

More Theriva Biologics figures

See a number that looks wrong?